Set the minimum documentation for pharmaceutical export and distribution that is genuinely necessary, and stop there.
Managing Exports and International Distribution of Pharmaceutical Products
A structured, applied course in pharmaceutical export and distribution — designed to be used the week you return.
📍 Tunis🗓️ 5 training days📚 4 modules🎓 Accredited certificate
5intensive training days
4scientific modules
8training sessions
32detailed points
Course Overview
Variation in pharmaceutical export and distribution between shifts and sites is where avoidable harm lives. In healthcare, a weakness in export and distribution is eventually paid for by a patient. Progress on this strand of health and pharmaceutical services is usually lost in the gap between approval and execution. The course covers pharmaceutical export and distribution at the level of detail needed to act, and stops there. Where the health and pharmaceutical services capability is measured, it improves; where it is only discussed, it drifts. It is appropriate for those preparing to take on wider responsibility for export and distribution. Each session closes with a decision the participant must justify about pharmaceutical export and distribution in their own setting. Participants take away a working set of documents supporting export and distribution, ready to be adapted internally. Participants leave with a first-ninety-days plan for this part of health and pharmaceutical services rather than a set of notes.
Expected Learning Outcomes
Apply root cause analysis to adverse events involving export and distribution.
Plan staffing and rota cover appropriate to demand in pharmaceutical export and distribution.
Manage the supply chain and cold chain supporting export and distribution.
Prepare a short, evidence-based briefing on pharmaceutical export and distribution for senior management.
Diagnose whether a problem in export and distribution is one of design, resourcing or discipline.
Build continuing professional development sustaining competence in pharmaceutical export and distribution.
Who Should Attend
Quality and patient safety officers monitoring pharmaceutical export and distribution.
Health information and records staff supporting export and distribution.
Supply chain and biomedical staff supporting pharmaceutical export and distribution.
Project and programme managers whose delivery depends on export and distribution.
Finance managers costing services delivered through pharmaceutical export and distribution.
Risk managers assessing the exposure created by export and distribution.
Course Modules
Pharmaceutical export and distribution: supply, cold chain and availability
2 sessions · 8 pointsSession 1Choosing indicators for pharmaceutical export and distribution that reflect outcome
- Cost pharmaceutical export and distribution per episode and identify avoidable waste.
- Assemble the accreditation evidence pack for export and distribution.
- Name a single owner for each element of pharmaceutical export and distribution.
- Close out actions on export and distribution rather than leaving them open indefinitely.
Session 2What patients actually experience during export and distribution
- Test the procedure for pharmaceutical export and distribution against a realistic scenario.
- Plan the sequence in which improvements to export and distribution will be introduced.
- Apply structured root cause analysis to the last adverse event involving pharmaceutical export and distribution.
- Map the clinical workflow for export and distribution as it is actually performed.
Export and distribution: confidentiality, consent and ethics
2 sessions · 8 pointsSession 1Escalation and decision rights in export and distribution
- Draft the minimum viable clinical protocol for pharmaceutical export and distribution.
- Verify six months later that changes to export and distribution have held.
- Audit pharmaceutical export and distribution by observing practice, not by reading policy.
- Confirm licensing and regulatory requirements applying to export and distribution are met.
Session 2Moving export and distribution from approval to execution
- Build medication safety checks into pharmaceutical export and distribution at the point of highest risk.
- Identify infection transmission risks created by export and distribution and control them.
- Establish who is informed, consulted and accountable in pharmaceutical export and distribution.
- Define escalation criteria for deterioration detected through export and distribution.
Export and distribution: quality indicators and patient outcome
2 sessions · 8 pointsSession 1The paperwork for export and distribution that is actually needed
- Check that pharmaceutical export and distribution still works when volumes rise unexpectedly.
- Remove steps in export and distribution that add effort without adding assurance.
- Plan continuity of pharmaceutical export and distribution during surge and outbreak conditions.
- Reduce unwarranted variation in export and distribution between shifts and sites.
Session 2Infection risk created by pharmaceutical export and distribution
- Confirm competence and continuing development for staff delivering pharmaceutical export and distribution.
- Check that consent processes within export and distribution are genuinely informed.
- Agree what will be standardised in pharmaceutical export and distribution and what will not.
- Measure patient experience of export and distribution and feed it back to the team.
Export and distribution: infection prevention and patient safety
2 sessions · 8 pointsSession 1Making incident reporting on export and distribution safe for staff
- Verify cold chain and storage conditions for materials used in pharmaceutical export and distribution.
- Decide what will be stopped to create capacity for export and distribution.
- Rank the weaknesses in pharmaceutical export and distribution by consequence rather than by ease of fixing.
- Record the rationale for each significant choice made about export and distribution.
Session 2The evidence assessors will ask for on export and distribution
- Confirm the incident reporting route for pharmaceutical export and distribution is quick and non-punitive.
- Define the trigger that would require export and distribution to be redesigned.
- Confirm that contractual obligations around pharmaceutical export and distribution are understood.
- Identify single points of dependency in export and distribution and reduce them.
Choose the package that suits you
Silver Package
At least 3 people
USD1,250
- Workshop or Program Participation
- Airport Transfers
- Customized Badge
- Expert Mentorship (Private Sessions)
- Supervision & Secretarial Services
- Accredited Certificate of Participation
- Complete Training Kit
- Coffee Break
- Closing Ceremony
Gold Package
At least 3 people
USD1,850
- 5-night stay in a 5-star hotel
- Workshop or Program Participation
- Airport Transfers
- Customized Badge
- Expert Mentorship (Private Sessions)
- Supervision & Secretarial Services
- Accredited Certificate of Participation
- Complete Training Kit
- Coffee Break
- Closing Ceremony
Complete your registration
We will contact you within one business day to confirm.